NXTM Share Price

Open 26.83 Change Price %
High 27.50 1 Day -0.22 -0.82
Low 26.54 1 Week 0.38 1.45
Close 26.58 1 Month -1.98 -6.93
Volume 220815 1 Year 11.62 77.67
52 Week High 29.99
52 Week Low 14.23
NXTM Important Levels
Resistance 2 27.47
Resistance 1 27.10
Pivot 26.87
Support 1 26.06
Support 2 25.69
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
FTR 2.02 2.02%
FTR 2.02 2.02%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.10 100.00%
VALV 0.04 100.00%
PTSX 0.21 90.91%
LOCM 0.09 50.00%
QKLS 0.15 50.00%
PFMT 2.41 31.69%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

NxStage Medical, Inc. (NASDAQ: NXTM)

NXTM Technical Analysis 2
As on 29th Mar 2017 NXTM Share Price closed @ 26.58 and we RECOMMEND Buy for LONG-TERM with Stoploss of 23.91 & Strong Sell for SHORT-TERM with Stoploss of 27.73 we also expect STOCK to react on Following IMPORTANT LEVELS.
NXTM Target for March
1st Target up-side 30.65
2nd Target up-side 32.11
3rd Target up-side 33.57
1st Target down-side 26.47
2nd Target down-side 25.01
3rd Target down-side 23.55
NXTM Other Details
Segment EQ
Market Capital 626582144.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.nxstage.com
NXTM Address
NXTM
350 Merrimack Street
Lawrence, MA 01843
United States
Phone: 978-687-4700
NXTM Latest News
Interactive Technical Analysis Chart NxStage Medical, Inc. ( NXTM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NxStage Medical, Inc.
NXTM Business Profile
NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company�s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). It operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it derives its revenues from the sale and rental of the System One and PureFlow SL equipment, and the sale of disposable products in the home and critical care markets. In the In-Center segment, it derives its revenues from the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis, which is referred to as the in-center market.